CN103041172B - 用于治疗慢性鼻窦炎的中药组合物及其制备方法 - Google Patents
用于治疗慢性鼻窦炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103041172B CN103041172B CN201210590786.8A CN201210590786A CN103041172B CN 103041172 B CN103041172 B CN 103041172B CN 201210590786 A CN201210590786 A CN 201210590786A CN 103041172 B CN103041172 B CN 103041172B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- weight portions
- radix
- volatile oil
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 182
- 239000000203 mixture Substances 0.000 title claims abstract description 114
- 238000002360 preparation method Methods 0.000 title claims description 20
- 230000001684 chronic effect Effects 0.000 title abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 61
- 239000004863 Frankincense Substances 0.000 claims abstract description 30
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 241000931143 Gleditsia sinensis Species 0.000 claims abstract description 16
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 12
- 230000001954 sterilising effect Effects 0.000 claims abstract description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 144
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 124
- 239000000341 volatile oil Substances 0.000 claims description 124
- 239000000706 filtrate Substances 0.000 claims description 118
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 106
- 239000000843 powder Substances 0.000 claims description 79
- 239000012153 distilled water Substances 0.000 claims description 78
- 239000000243 solution Substances 0.000 claims description 73
- 239000007788 liquid Substances 0.000 claims description 64
- 238000011282 treatment Methods 0.000 claims description 58
- 238000001914 filtration Methods 0.000 claims description 51
- 241000628997 Flos Species 0.000 claims description 42
- 239000009670 cang er zi wan Substances 0.000 claims description 40
- 238000003756 stirring Methods 0.000 claims description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- 206010009137 Chronic sinusitis Diseases 0.000 claims description 32
- 208000027157 chronic rhinosinusitis Diseases 0.000 claims description 32
- 238000004821 distillation Methods 0.000 claims description 32
- 238000003809 water extraction Methods 0.000 claims description 32
- 241000717739 Boswellia sacra Species 0.000 claims description 28
- 239000007923 nasal drop Substances 0.000 claims description 26
- 238000010438 heat treatment Methods 0.000 claims description 24
- 241000756943 Codonopsis Species 0.000 claims description 21
- 239000006071 cream Substances 0.000 claims description 21
- 239000007921 spray Substances 0.000 claims description 21
- 238000005507 spraying Methods 0.000 claims description 21
- 239000002552 dosage form Substances 0.000 claims description 18
- 238000005325 percolation Methods 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 17
- 238000001816 cooling Methods 0.000 claims description 16
- 238000007598 dipping method Methods 0.000 claims description 16
- 238000004321 preservation Methods 0.000 claims description 16
- 230000001105 regulatory effect Effects 0.000 claims description 16
- 241001250596 Pleione Species 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 15
- 241000155668 Siphonostegia chinensis Species 0.000 claims description 14
- 241000244155 Taenia Species 0.000 claims description 14
- 230000001476 alcoholic effect Effects 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 14
- 230000006837 decompression Effects 0.000 claims description 14
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 14
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 14
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 14
- 239000008517 radix Trichosanthis Substances 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 14
- 239000002024 ethyl acetate extract Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 230000002829 reductive effect Effects 0.000 claims description 9
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 4
- 238000003958 fumigation Methods 0.000 claims description 3
- 239000007922 nasal spray Substances 0.000 claims description 3
- 229940097496 nasal spray Drugs 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 62
- 208000002193 Pain Diseases 0.000 abstract description 33
- 230000036407 pain Effects 0.000 abstract description 27
- 206010059866 Drug resistance Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 3
- 235000011477 liquorice Nutrition 0.000 abstract 3
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 2
- 240000007551 Boswellia serrata Species 0.000 abstract 2
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 2
- 241000928504 Centipeda minima Species 0.000 abstract 2
- 241000207925 Leonurus Species 0.000 abstract 2
- 244000067505 Xanthium strumarium Species 0.000 abstract 2
- 241001529821 Agastache Species 0.000 abstract 1
- 240000002234 Allium sativum Species 0.000 abstract 1
- 241000031023 Amana edulis Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000014290 Artemisia anomala Nutrition 0.000 abstract 1
- 241000123844 Artemisia anomala Species 0.000 abstract 1
- 241000167854 Bourreria succulenta Species 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 241000218394 Magnolia liliiflora Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 241001162994 Rugosus Species 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 abstract 1
- 240000001519 Verbena officinalis Species 0.000 abstract 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 abstract 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 abstract 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 abstract 1
- 235000019693 cherries Nutrition 0.000 abstract 1
- 235000004611 garlic Nutrition 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 69
- 239000008280 blood Substances 0.000 description 51
- 210000004369 blood Anatomy 0.000 description 50
- 210000000952 spleen Anatomy 0.000 description 48
- 206010011224 Cough Diseases 0.000 description 34
- 210000002784 stomach Anatomy 0.000 description 30
- 206010062717 Increased upper airway secretion Diseases 0.000 description 29
- 208000026435 phlegm Diseases 0.000 description 29
- 206010030113 Oedema Diseases 0.000 description 26
- 241001465754 Metazoa Species 0.000 description 24
- 210000004185 liver Anatomy 0.000 description 24
- 210000001331 nose Anatomy 0.000 description 24
- 201000009890 sinusitis Diseases 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 18
- 230000008961 swelling Effects 0.000 description 18
- 206010028748 Nasal obstruction Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 201000010099 disease Diseases 0.000 description 16
- 231100000614 poison Toxicity 0.000 description 16
- 206010007247 Carbuncle Diseases 0.000 description 14
- 210000003928 nasal cavity Anatomy 0.000 description 14
- 230000001717 pathogenic effect Effects 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- 239000003440 toxic substance Substances 0.000 description 14
- 238000003304 gavage Methods 0.000 description 13
- 210000004877 mucosa Anatomy 0.000 description 13
- 230000028327 secretion Effects 0.000 description 13
- 206010019233 Headaches Diseases 0.000 description 12
- 206010039101 Rhinorrhoea Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 231100000869 headache Toxicity 0.000 description 12
- 230000008673 vomiting Effects 0.000 description 12
- 241000700199 Cavia porcellus Species 0.000 description 11
- 206010047700 Vomiting Diseases 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 210000003695 paranasal sinus Anatomy 0.000 description 11
- 238000010171 animal model Methods 0.000 description 10
- 108010074051 C-Reactive Protein Proteins 0.000 description 9
- 102100032752 C-reactive protein Human genes 0.000 description 9
- 208000033809 Suppuration Diseases 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 9
- 210000002850 nasal mucosa Anatomy 0.000 description 9
- 201000000736 Amenorrhea Diseases 0.000 description 8
- 206010001928 Amenorrhoea Diseases 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 208000005171 Dysmenorrhea Diseases 0.000 description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 231100000540 amenorrhea Toxicity 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 239000003172 expectorant agent Substances 0.000 description 8
- 230000003419 expectorant effect Effects 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 230000001939 inductive effect Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 208000010753 nasal discharge Diseases 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 231100000111 LD50 Toxicity 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000003128 head Anatomy 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000001575 pathological effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000003014 reinforcing effect Effects 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 102000004889 Interleukin-6 Human genes 0.000 description 5
- 108090001005 Interleukin-6 Proteins 0.000 description 5
- 241000158526 Nasalis Species 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 208000013116 chronic cough Diseases 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 229940100601 interleukin-6 Drugs 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 230000037452 priming Effects 0.000 description 5
- 230000001047 pyretic effect Effects 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 201000005702 Pertussis Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 231100001252 long-term toxicity Toxicity 0.000 description 4
- 201000003453 lung abscess Diseases 0.000 description 4
- 210000004086 maxillary sinus Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 210000003516 pericardium Anatomy 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 208000004371 toothache Diseases 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 206010037569 Purulent discharge Diseases 0.000 description 3
- 208000036071 Rhinorrhea Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000001174 ascending effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 210000004081 cilia Anatomy 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000007436 olfactory function Effects 0.000 description 3
- 201000001245 periodontitis Diseases 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 206010064012 Central pain syndrome Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010018275 Gingival atrophy Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 241000237955 Nassarius Species 0.000 description 2
- 238000011887 Necropsy Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 208000006735 Periostitis Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010042170 Strangury Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000002547 anomalous effect Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000002973 anti-dopamine Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000000680 avirulence Effects 0.000 description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 2
- 229960003321 baicalin Drugs 0.000 description 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000001886 ciliary effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- -1 filter Substances 0.000 description 2
- YLRFCQOZQXIBAB-RBZZARIASA-N fluoxymesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)C[C@@H]2O YLRFCQOZQXIBAB-RBZZARIASA-N 0.000 description 2
- 201000005562 gingival recession Diseases 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 230000001861 immunosuppressant effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 2
- 229960000349 nitrofural Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 210000003460 periosteum Anatomy 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 206010002653 Anosmia Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241001415830 Bubo Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010050515 Hyposmia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 241000220261 Sinapis Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- UGAPHEBNTGUMBB-UHFFFAOYSA-N acetic acid;ethyl acetate Chemical compound CC(O)=O.CCOC(C)=O UGAPHEBNTGUMBB-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000016335 bubo Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000002729 catgut Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 235000019559 hyposmia Nutrition 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Abstract
Description
组别 | n | IL-6 | CRP |
空白组 | 10 | 35.294±1.853 | 6.071±1.210 |
模型组 | 10 | 74.496±2.008 | 29.871±1.572 |
治疗组 | 10 | 40.227±2.071 | 6.594±1.621 |
组别 | 治疗前 | 3个疗程 | 6个疗程 |
治疗组 | 11.9±2.6 | 9.8±1.9 | 6.4±2.1 |
对照组 | 10.8±1.7 | 10.3±1.1 | 9.2±2.4 |
组别 | 治疗前 | 3个疗程 | 6个疗程 |
治疗组 | 30.7±9.1 | 18.9±7.2 | 7.3±3.1 |
对照组 | 29.3±8.8 | 23.6±6.9 | 14.1±5.1 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210590786.8A CN103041172B (zh) | 2012-12-29 | 2012-12-29 | 用于治疗慢性鼻窦炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210590786.8A CN103041172B (zh) | 2012-12-29 | 2012-12-29 | 用于治疗慢性鼻窦炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103041172A CN103041172A (zh) | 2013-04-17 |
CN103041172B true CN103041172B (zh) | 2014-07-02 |
Family
ID=48054183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210590786.8A Expired - Fee Related CN103041172B (zh) | 2012-12-29 | 2012-12-29 | 用于治疗慢性鼻窦炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103041172B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103041313B (zh) * | 2013-01-11 | 2014-05-28 | 周国生 | 一种治疗鼻窦炎的中药 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480189A (zh) * | 2003-07-10 | 2004-03-10 | 姜延德 | 一种治疗鼻炎的药物 |
CN101332279A (zh) * | 2008-07-15 | 2008-12-31 | 何社明 | 治疗鼻窦炎、鼻息肉和鼻咽炎的中药制剂 |
CN101422550A (zh) * | 2007-10-29 | 2009-05-06 | 杜月赞 | 一种治疗慢性鼻窦炎的药物 |
-
2012
- 2012-12-29 CN CN201210590786.8A patent/CN103041172B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1480189A (zh) * | 2003-07-10 | 2004-03-10 | 姜延德 | 一种治疗鼻炎的药物 |
CN101422550A (zh) * | 2007-10-29 | 2009-05-06 | 杜月赞 | 一种治疗慢性鼻窦炎的药物 |
CN101332279A (zh) * | 2008-07-15 | 2008-12-31 | 何社明 | 治疗鼻窦炎、鼻息肉和鼻咽炎的中药制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN103041172A (zh) | 2013-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102696928B (zh) | 用于治疗猪流感的饲料、中药组合物、制备方法和应用 | |
CN103393945B (zh) | 一种治疗风热犯肺型咳嗽的中药 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN103120760B (zh) | 用于治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN103520605B (zh) | 用于治疗柔嫩艾美尔球虫感染的饲料 | |
CN103182064A (zh) | 一种治疗风寒咳嗽的药物及其制备方法 | |
CN104474104A (zh) | 一种防治鸡传染性鼻炎的中药组合物及其制备方法 | |
CN103028060B (zh) | 用于治疗婴幼儿急性湿疹的中药组合物及其制备方法 | |
CN104784549A (zh) | 用于治疗变应性鼻炎的内服中药 | |
CN104771578A (zh) | 用于治疗变应性鼻炎的中药 | |
CN103041172B (zh) | 用于治疗慢性鼻窦炎的中药组合物及其制备方法 | |
CN103028041B (zh) | 用于治疗儿童急性鼻窦炎的中药组合物及其制备方法 | |
CN103028040B (zh) | 用于治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
CN103028046B (zh) | 用于治疗萎缩性鼻炎的中药组合物及其制备方法 | |
CN102727738B (zh) | 用于治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN106039074A (zh) | 治疗犬细小病毒的药片 | |
CN105998725A (zh) | 用于治疗矽肺的中药制剂 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN103041194B (zh) | 用于治疗慢性湿疹的中药组合物及其制备方法 | |
CN103705856B (zh) | 用于预防放化疗急性放射反应的中药组合物 | |
CN103341151B (zh) | 用于治疗慢性支气管炎的中药 | |
CN103055299B (zh) | 用于治疗缓慢性心律失常的中药组合物及其制备方法 | |
CN105963586A (zh) | 一种治疗肺脓肿的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Chonghui Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: WANG CHONGHUI |
|
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171020 Address after: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee after: Chongqing AOPO Ruisen Technology Co. Ltd. Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Patentee before: Qingdao Hengbo Instrument Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180328 Address after: 401120 Chongqing Yubei District Hui Xing Street Xingke Road No. 293 with mountain name 7 9 Patentee after: CHONGQING XUANNU BIOTECHNOLOGY CO., LTD. Address before: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee before: Chongqing AOPO Ruisen Technology Co. Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140702 Termination date: 20181229 |
|
CF01 | Termination of patent right due to non-payment of annual fee |